Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2011 (Vol. 31, No. 2)

The Sánchez Laboratory

  • Good page design, nice list of links
  • Not too much content overall

The laboratory of Alejandro Sánchez Alvarado at the University of Utah is like a spa, in that both are concerned with regeneration. Yet, instead of using cucumbers and mud masks, the members of the Sánchez laboratory are more interested in regeneration of the planarian type. On the lab website, visitors can watch movies of the planarian research participants that deal with stem cell lineage and regeneration. The “In the News” tab provides recent items of note in the neurobiology regeneration field, while the “Links” page provides links to some other planarian research labs, planarian resources in general, and other miscellaneous links. While the website isn’t teeming with information for the professional planarian researcher, the page is nicely designed and is a good starting point to learn a bit about this field of research and find some other like-minded laboratories.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »